• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Wednesday, May 25, 2016

    Offline Date

    Sunday, November 25, 2018

    ACPE Expiration Date

    Sunday, November 25, 2018

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $4.00

    • Overview

      The guideline governing the management of dyslipidemia was recently revised at the end of 2013. Several critical changes were made to the guideline, including the elimination of specific lipid goals, a new method to calculate cardiovascular risk, identification of four groups where treatment benefit clearly outweighs risk, and a stronger focus on statin therapy. It is imperative to disseminate these updates to healthcare practitioners, so that they can provide evidence-based, patient-centered care as members of an interdisciplinary team.

      Rating

         4.50  out of 5

      Handouts

      • Slide Document :   shifting_completeho_4pp.pdf
      • Slide Document :   shifting_completeho_2pp.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      Describe the background of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD)
      Calculate ASCVD risk using the Pooled Cohort Equations CV Risk Calculator
      Identify patient-specific pharmacotherapy plans to optimize outcomes for patients with dyslipidemia
      Recognize the role of pharmacotherapy in dyslipidemia management
      Review recommendations from the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

      Pharmacy Technician

      Describe the background of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD)
      Review the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
      Recognize the role of pharmacotherapy in dyslipidemia management

      Nurse

      Calculate ASCVD risk using the Pooled Cohort Equations CV Risk Calculator
      Recognize the role of pharmacotherapy in dyslipidemia management
      Describe the background of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD)
      Review recommendations from the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
      Identify patient-specific pharmacotherapy plans to optimize outcomes for patients with dyslipidemia
    • Activity Type

      Knowledge

      CE Broker

      20-523320

      Universal Activity Number

      Pharmacist 0798-0000-15-143-H01-P
      Pharmacy Technician 0798-0000-15-143-H01-T
      Nurse 0798-0000-15-143-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).